Listed

Creative Medical Technology Holdings, Inc.: Form 10-Q for the period ended Mar 31, 2015

Filed with the SEC on May 8, 2015 and accepted by EDGAR at May 8, 2015, 16:47 ET.

Share

Management's discussion and analysis

As filed, 5,789 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Forward-Looking Statement Notice

This Form 10-Q contains certain forward-looking statements. For this purpose any statements contained in this Form 10-Q that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, words such as “may,” “expect,” “believe,” “anticipate,” “estimate” or “continue” or comparable terminology are intended to identify forward-looking statements. These statements by their nature involve substantial risks and uncertainties, and actual results may differ materially depending on a variety of factors, many of which are not within our control. These factors include but are not limited to economic conditions generally and in the industries in which we may participate; competition within our chosen industry, including competition from much larger competitors; changes in rules or regulations relating to shell companies; technological advances and failure to successfully develop business relationships.

Overview

General

Jolley Marketing, Inc. was incorporated on December 3, 1998, in the State of Nevada. Our company has assets of nominal value and we have generated no revenue since September 2008. We are a “shell company” as defined pursuant to Rule 12b-2 under the Securities Exchange Act of 1934 (the “Exchange Act”). We intend to seek to acquire the assets or voting securities of one or more other companies that are actively engaged in a business that generates revenues in exchange for securities of our company, or to be acquired by such a company. We have not identified a particular acquisition target or entered into any negotiations regarding any acquisition.

Our Company currently intends to remain a shell company until a merger or acquisition is consummated. We currently anticipate that our Company’s cash requirements will be minimal until we complete such a merger or acquisition and that our sole director and officer, or his affiliates, will provide the financing that may be required for our limited operations prior to completing such a transaction. We currently have no employees. Our sole director and officer has agreed to allocate a portion of his time to the activities of our company, without cash compensation. He anticipates that we can implement our business plan by devoting a portion of his available time to our business affairs.

Three Month Periods Ended March 31, 2015 and 2014

Revenue

Our revenues for the three months ended March 31, 2015 and 2014, were $0 and $0, respectively.

Operating Expenses

For the three months ended March 31, 2015, operating expenses were $9,272, consisting of $6,892 in professional fees, interest expense of $2,280 and other general expenses of $100. For the three months ended March 31, 2014, operating expenses were $10,015, consisting of $7,964 in professional fees, interest expense of $1,976 and other general expenses of $75. Operating expenses decreased from 2014 to 2015 due to a decrease in audit fees offset by an increase in interest expense due to an increase in the notes payable.

Net Loss

Our net losses for the three months ended March 31, 2015 and 2014 were $9,272 and $10,015, respectively, which resulted in a net loss per share of $0.00 for each period.

Liquidity and Capital Resources

The Company’s balance sheet as of March 31, 2015, reflects total current assets of $583 consisting of cash. As of March 31, 2015, our current liabilities were $162,898 which included $12,507 in accounts payable, $121,000 in notes payable to related parties, and $29,391 in interest payable.

We anticipate our expenses to be limited to accounting, auditing, legal and filing fees associated with continuing our reporting status with the Securities and Exchange Commission along with miscellaneous expenses related to our corporate existence. We estimate our ongoing expenses to be $30,000 per year. We do not have any commitments for capital expenditures nor do we anticipate entering into any such commitments. We will likely need additional funds to cover our expenses for the next year.

In the past we have relied on advances from a related party to cover our operating costs. Management anticipates that we will receive sufficient advances to meet our needs through the next 12 months. However, there can be no assurances to that effect. Our need for capital may change dramatically if we acquire an interest in a business opportunity during that period. At present, we have no understandings, commitments or agreements with respect to the acquisition of any business venture, and there can be no assurance that we will identify a business venture suitable for acquisition in the future. Further, we cannot assure that we will be successful in consummating any acquisition on favorable terms or that we will be able to profitably manage any business venture we acquire. Should we require additional capital, we may seek additional advances from officers, sell common stock or find other forms of debt financing.

The Company has no other assets or line of credit, other than that which present management may agree to extend to or invest in the Company, nor does it expect to have one before a merger is affected. The Company will carry out its business plan as discussed above. The Company cannot predict to what extent its liquidity and capital resources will be diminished prior to the consummation of a business combination or whether its capital will be further depleted by the operating losses (if any) of the business entity which the Company may eventually acquire.

Our current operating plan is to continue searching for potential businesses, products, technologies and companies for acquisition and to handle the administrative and reporting requirements of a public company.

Controls and procedures

As filed, 1,250 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures. Our management, with the participation of our president who is also our principal financial officer, carried out an evaluation of the effectiveness of our "disclosure controls and procedures" (as defined in the Securities Exchange Act of 1934 (the "Exchange Act") Rule 13a-15(e)) as of the end of the period covered by this report (the "Evaluation Date"). Based upon that evaluation, our president concluded that, as of the Evaluation Date, our disclosure controls and procedures are not effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act (i) is recorded, processed, summarized and reported, within the time periods specified in the SEC's rules and forms and (ii) is accumulated and communicated to our management, including our president, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting. There were no changes in our internal control over financial reporting that occurred during the quarter ended March 31, 2015 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2015-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2015-01-01 to 2015-03-31$0us-gaap:Revenues
Operating income3 months2015-01-01 to 2015-03-31−$7.0kus-gaap:OperatingIncomeLoss
Net income3 months2015-01-01 to 2015-03-31−$9.3kus-gaap:NetIncomeLoss
Diluted EPS3 months2015-01-01 to 2015-03-31$0.00us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow3 months2015-01-01 to 2015-03-31−$5.4kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2015-03-31$583us-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2015-03-31$583us-gaap:AssetsCurrent
Total assetsAt period end2015-03-31$583us-gaap:Assets
Current liabilitiesAt period end2015-03-31$162.9kus-gaap:LiabilitiesCurrent
Shareholders' equityAt period end2015-03-31−$162.3kus-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Source: SEC EDGAR, the filing index for accession 0001078782-15-000730. Last ingested by Listed: Nov 14, 2026, 19:08 ET. Listed shows no prices and gives no investment advice.